专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP0772606A1 SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION 失效
标题翻译：取代噻唑用于炎症的治疗
公开(公告)号：EP0772606A1
公开(公告)日：1997-05-14
申请号：EP95928145.0
申请日：1995-07-26
申请人： G.D. SEARLE & CO.
发明人： TALLEY, John, J. , CARTER, Jeffery, S. , COLLINS, Paul, W. , KRAMER, Steven, W. , PENNING, Thomas, D. , ROGIER, Donald, J., Jr. , ROGERS, Roland, S.
IPC分类号： C07D277 , A61K31 , A61P3 , A61P29 , C07D417
CPC分类号： C07D417/04 , C07D277/26 , C07D277/30 , C07D277/42 , C07D277/56 , C07D417/12
摘要： A class of substituted thiazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula (II), wherein R4 is selected from alkyl and amino, wherein R5 is selected from aryl, cycloalkyl, cycloalkenyl and heterocyclic; wherein R5 is optionally substituted at a substitutable position with one or more radicals selected from halo, alkylthio, alkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, aminosulfonyl, alkyl, alkenyl, alkynyl, cyano, carboxyl, carboxyalkyl, alkoxycarbonyl, aminocarbonyl, acyl, N-alkylaminocarbonyl, N-arylaminocarbonyl, N,N-dialkylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, haloalkyl, hydroxyl, alkoxy, hydroxyalkyl, haloalkoxy, amino, N-alkylamino, N,N-dialkylamino, heterocyclic and nitro; and wherein R6 is selected from halo, amino, alkoxy, nitro, hydroxyl, aminocarbonyl, acyl, alkylaminocarbonyl, arylaminocarbonyl, alkenyl, alkynyl, haloalkoxy, alkylamino, arylamino, aralkylamino, alkoxycarbonylalkyl, alkylaminoalkyl, heterocycloalkyl, aralkyl, cyanoalkyl, N-alkylsulfonylamino, heteroarylsulfonylalkyl, heteroarylsulfonylhaloalkyl, aryloxyalkyl, aralkyloxyalkyl, aryl and heterocyclo, wherein the aryl and heterocyclo radicals are optionally substituted at a substitutable position with one or more radicals selected from halo, alkyl, alkoxy, alkylthio, alkylsulfinyl, haloalkyl, haloalkoxy, carboxyalkyl, alkoxycarbonyl, aminocarbonyl, amino, acyl and alkylamino; or a pharmaceutically-acceptable salt thereof.

2. 发明公开

EP0731795A1 SUBSTITUTED PYRAZOLYL BENZENESULFONAMIDES FOR THE TREATMENT OF INFLAMMATION 有权转让
标题翻译：取代的吡唑苯磺酰胺用于炎症的治疗
公开(公告)号：EP0731795A1
公开(公告)日：1996-09-18
申请号：EP95902444.0
申请日：1994-11-14
申请人： G.D. SEARLE & CO.
发明人： TALLEY, John, J. , PENNING, Thomas, D. , COLLINS, Paul, W. , ROGIER, Donald, J., Jr. , MALECHA, James, W. , MIYASHIRO, Julie M. , BERTENSHAW, Stephen, R. , KHANNA, Ish, K. , GRANETS, Matthew, J. , ROGERS, Roland, S. , CARTER, Jeffery, S. , DOCTER, Stephen, H. , YU, Stella, S.
IPC分类号： A61K31 , A61P5 , A61P9 , A61P19 , A61P25 , A61P29 , C07D231 , C07D401 , C07D403 , C07D405 , C07D409 , C07D413 , C07D495
CPC分类号： C07D495/04 , C07D231/12 , C07D231/14 , C07D231/16 , C07D231/54 , C07D401/04 , C07D403/04 , C07D405/04 , C07D409/04
摘要： A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (II), whrein R2 is selected from hydrido, alkyl, haloalkyl, alkoxycarbonyl, cyano, cyanoalkyl, carboxyl, aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl, arylaminocarbonyl, carboxyalkylaminocarbonyl, carboxyalkyl, aralkoxycarbonylalkylaminocarbonyl, aminocarbonylalkyl, alkoxycarbonylcyanoalkenyl and hydroxyalkyl; wherein R3 is selected from hydrido, alkyl, cyano, hydroxyalkyl, cycloalkyl, alkylsulfonyl and halo; and wherein R4 is selected from aralkenyl, aryl, cycloalkyl, cycloalkenyl and heterocyclic; wherein R4 is optionally substituted at a substitutable position with one or more radicals selected from halo, alkylthio, alkylsulfonyl, cyano, nitro, haloalkyl, alkyl, hydroxyl, alkenyl, hydroxyalkyl, carboxyl, cycloalkyl, alkylamino, dialkylamino, alkoxycarbonyl, aminocarbonyl, alkoxy, haloalkoxy, sulfamyl, heterocyclic and amino; provided R?2 and R3¿ are not both hydrido; further provided that R2 is not carboxyl or methyl when R3 is hydrido and when R4 is phenyl; further provided that R4 is not triazolyl when R2 is methyl; further provided that R4 is not aralkenyl when R2 is carboxyl, aminocarbonyl or ethoxycarbonyl; further provided that R4 is not phenyl when R2 is methyl and R3 is carboxyl; and further provided that R4 is not unsubstituted thienyl when R2 is trifluoromethyl; or a pharmaceutically acceptable salt thereof.

3. 发明公开

EP0891325A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS 失效
标题翻译： PARA取代物，苯丙INTEGRIM拮抗剂
公开(公告)号：EP0891325A1
公开(公告)日：1999-01-20
申请号：EP97916852.0
申请日：1997-03-26
申请人： G.D. SEARLE & CO.
发明人： CHEN, Barbara, B. , CHEN, Helen, Y. , GESICKI, Glen, J. , HAACK, Richard, A. , MALECHA, James, W. , PENNING, Thomas, D. , RICO, Joseph, G. , ROGERS, Thomas, E. , RUMINSKI, Peter, G. , RUSSELL, Mark, A. , YU, Stella, S.
IPC分类号： A61K31 , A61P9 , A61P19 , A61P27 , A61P35 , C07C257 , C07C259 , C07C275 , C07C279 , C07C311 , C07C317 , C07C323 , C07D223 , C07D233 , C07D239 , C07D249 , C07D271 , C07D295 , C07D521
CPC分类号： C07D271/07 , A61K31/155 , C07C275/42 , C07C279/18 , C07C279/22 , C07C279/24 , C07C279/28 , C07C311/06 , C07C311/13 , C07C311/19 , C07C311/64 , C07C317/44 , C07C323/52 , C07D223/12 , C07D231/12 , C07D233/50 , C07D233/56 , C07D233/88 , C07D239/14 , C07D249/08 , C07D249/14 , C07D295/215
摘要： The present invention relates to a class of compounds represented by Formula (I) or a phramaceutically acceptable salt thereof, pharmaceutical composition comprising compounds of Formula (I), and methods of selectively inhibiting or antagonizing the αvβ3 integrin.

4. 发明授权

EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS 失效
标题翻译： N - [[4-（5-甲基-3-苯基恶唑-4-基]苯基]苯基]丙基]氨基]苯并咪唑盐酸盐
公开(公告)号：EP0892791B1
公开(公告)日：2003-03-05
申请号：EP97921092.9
申请日：1997-04-11
申请人： G.D. SEARLE & CO.
发明人： TALLEY, John, J. , MALECHA, James, W. , BERTENSHAW, Stephen , GRANETO, Matthew, J. , CARTER, Jeffery, S. , LI, Jinglin , NAGARAJAN, Srinivasan , BROWN, David, L. , ROGIER, Donald, J., Jr. , PENNING, Thomas, D. , KHANNA, Ish, K. , XU, Xiangdong , WEIER, Richard, M.
IPC分类号： C07D261/08 , C07D233/54 , C07D401/04 , A61K31/42 , A61K31/415 , C07D231/12 , C07D495/04 , C07D263/32 , C07C311/39 , C07D207/32 , C07D307/58
CPC分类号： C07D207/33 , A61K31/18 , A61K31/415 , A61K31/42 , A61K31/635 , C07C311/16 , C07C311/51 , C07C2601/10 , C07D231/12 , C07D233/64 , C07D261/08 , C07D263/32 , C07D307/58 , C07D401/04 , C07D417/04 , C07D495/04
摘要： Prodrugs of COX-2 inhibitors of formula (I) are described as being useful in treating inflammation and inflammation-related disorders wherein A is a ring substituent selected from partially unsaturated heterocyclyl, heteroaryl, cycloalkenyl and aryl, wherein A is optionally substituted at a substitutable position with one or more radicals selected from alkylcarbonyl, formyl, halo, alkyl, haloalkyl, oxo, cyano, nitro, carboxyl, alkoxy, aminocarbonyl, alkoxycarbonyl, carboxyalkyl, cyanoalkyl, hydroxyalkyl, haloalkylsulfonyloxy, alkoxyalkyloxyalkyl, carboxyalkoxyalkyl, cycloalkylalkyl, alkenyl, alkynyl, heterocyclyloxy, alkylthio, cycloalkyl, aryl, heterocyclyl, cycloalkenyl, aralkyl, heterocyclylalkyl, alkylthioalkyl, arylcarbonyl, aralkylcarbonyl, aralkenyl, alkoxyalkyl, arylthioalkyl, aryloxyalkyl, aralkylthioalkyl, aralkoxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonyl, N-arylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, alkylaminocarbonylalkyl, alkylamino, N-arylamino, N-aralkylamino, N-alkyl-N-aralkylamino, N-alkyl-N-arylamino, aminoalkyl, alkylaminoalkyl, N-arylaminoalkyl, N-aralkylaminoalkyl, N-alkyl-N-aralkylaminoalkyl, N-alkyl-N-arylaminoalkyl, aryloxy, aralkoxy, arylthio, aralkylthio, alkylsulfinyl, alkylsulfonyl, aminosulfonyl, alkylaminosulfonyl, N-arylaminosulfonyl, arylsulfonyl, and N-alkyl-N-arylaminosulfonyl; wherein R1 is selected from heterocyclyl, cycloalkyl, cycloalkenyl and aryl, wherein R1 is optionally substituted at a substitutable position with one or more radicals selected from alkyl, haloalkyl, cyano, carboxyl, alkoxycarbonyl, hydroxyl, hydroxyalkyl, haloalkoxy, amino, alkylamino, arylamino, nitro, alkoxyalkyl, alkylsulfinyl, halo, alkoxy and alkylthio; wherein R2 is selected from hydrido and alkoxycarbonylalkyl; and wherein R3 is selected from alkyl, carboxyalkyl, acyl, alkoxycarbonyl, heteroarylcarbonyl, alkoxycarbonylalkylcarbonyl, alkoxycarbonylcarbonyl, amino acid residue, and alkylcarbonylaminoalkylcarbonyl; provided A is not tetrazolium, or pyridinum; and further provided A is not indanone when R3 is alkyl or carboxyalkyl; or a pharmaceutically-acceptable salt thereof.
摘要翻译：描述了式（I）的COX-2抑制剂的前药可用于治疗炎症和炎症相关疾病，其中A是选自部分不饱和杂环基，杂芳基，环烯基和芳基的环取代基，其中A任选在可取代的位置与一个或多个选自烷基羰基，甲酰基，卤素，烷基，卤代烷基，氧代，氰基，硝基，羧基，烷氧基，氨基羰基，烷氧基羰基，羧基烷基，氰基烷基，羟基烷基，卤代烷基磺酰氧基，烷氧基烷氧基烷基，羧烷氧基烷基，环烷基烷基，烯基，炔基，芳烷基，芳烷基羰基，芳烷基，烷氧基烷基，芳硫基烷基，芳氧基烷基，芳烷硫基烷基，芳烷氧基烷基，烷氧基羰基烷基，氨基羰基烷基，烷基氨基羰基，N-芳基氨基羰基，N-烷基-N- 芳基氨基羰基，烷基氨基羰基烷基，烷基氨基，N-芳基不是N-芳烷基氨基，N-烷基-N-芳烷基氨基，N-烷基-N-芳基氨基，氨基烷基，烷基氨基烷基，N-芳基氨基烷基，N-芳烷基氨基烷基，N-烷基-N-芳烷基氨基烷基，N-烷基-N-芳基氨基烷基，芳氧基，芳烷氧基，芳硫基，芳烷硫基，烷基亚磺酰基，烷基磺酰基，氨基磺酰基，烷基氨基磺酰基，N-芳基氨基磺酰基，芳基磺酰基和N-烷基-N-芳基氨基磺酰基; 其中R 1选自杂环基，环烷基，环烯基和芳基，其中R 1在可取代位置任选被一个或多个选自烷基，卤代烷基，氰基，羧基，烷氧基羰基，羟基，羟基烷基，卤代烷氧基，氨基，烷基氨基，芳基氨基，硝基，烷氧基烷基，烷基亚磺酰基，卤素，烷氧基和烷硫基; 其中R 2选自氢化和烷氧基羰基烷基; 其中R 3选自烷基，羧基烷基，酰基，烷氧基羰基，杂芳基羰基，烷氧基羰基烷基羰基，烷氧基羰基羰基，氨基酸残基和烷基羰基氨基烷基羰基。提供A不是四唑或吡啶; 并且当R 3是烷基或羧基烷基时，A不是茚满酮; 或其药学上可接受的盐。

5. 发明授权

EP0894084B1 CINNAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRIN ANTAGONISTS 失效
标题翻译：肉桂酸衍生物和它们作为整拮抗剂的用途
公开(公告)号：EP0894084B1
公开(公告)日：2002-06-26
申请号：EP97916111.4
申请日：1997-03-25
申请人： G.D. SEARLE & CO.
发明人： CHEN, Barbara, B. , CHEN, Helen, Y. , CLARE, Michael , DOCTER, Stephen, H. , KHANNA, Ish, Kumar , KOSZYK, Francis, Jan , MALECHA, James, W. , MIYASHIRO, Julie, M. , PENNING, Thomas, D. , RICO, Joseph, G. , RUMINSKI, Peter, G. , RUSSELL, Mark, A. , WEIER, Richard, M. , XU, Xiangdong , YU, Stella, S. , YU, Yi
IPC分类号： C07C279/18 , A61K31/155 , C07D239/14 , C07D233/50 , C07D239/42 , C07D403/12 , C07D233/64 , C07D263/32 , C07D279/06 , C07C279/24 , A61K31/415
CPC分类号： C07D231/06 , C07C205/34 , C07C205/35 , C07C205/37 , C07C205/44 , C07C205/45 , C07C205/56 , C07C205/57 , C07C275/42 , C07C279/18 , C07C279/22 , C07C279/24 , C07D233/50 , C07D233/64 , C07D239/14 , C07D239/42 , C07D263/32 , C07D279/06 , C07D401/12 , C07D403/12
摘要： The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (I), and methods of selectively inhibiting or antagonizing the αvβ3 integrin.

6. 发明公开

EP0970060A1 LTA 4 HYDROLASE INHIBITORS 失效
标题翻译：水解酶 - 抑制剂LTA 4
公开(公告)号：EP0970060A1
公开(公告)日：2000-01-12
申请号：EP98908786.1
申请日：1998-03-06
申请人： G.D. SEARLE & CO.
发明人： CHEN, Barbara, B. , CHEN, Helen , RUSSELL, Mark, A. , MIYASHIRO, Julie, M. , MALECHA, James, W. , PENNING, Thomas, D.
IPC分类号： C07D263/32 , A61K31/445 , A61K31/42 , A61K31/425 , A61K31/40 , A61K31/195 , C07D295/08 , C07D211/62 , C07D277/24 , C07C229/12
CPC分类号： C07D295/088 , C07C229/12 , C07D211/62 , C07D263/32 , C07D277/24
摘要： The present invention provides compounds having structure (I) and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which are mediated by LTB4 production, such as psoriasis, ulcerative colitis, IBD, and asthma.

7. 发明授权

EP0679157B1 NOVEL 3,4-DIARYL THIOPHENES AND ANALOGS THEREOF HAVING USE AS ANTIINFLAMMATORY AGENTS 有权转让
标题翻译： 3,4-diarylthiophenes及其类似物，及其作为抗炎剂
公开(公告)号：EP0679157B1
公开(公告)日：1997-11-19
申请号：EP94906625.2
申请日：1994-01-14
申请人： G.D. SEARLE & CO. , THE MONSANTO COMPANY
发明人： BERTENSHAW, Stephen, R. , COLLINS, Paul, W. , PENNING, Thomas, D. , REITZ, David, B. , ROGERS, Roland, S.
IPC分类号： C07D333/18 , C07D333/16 , C07D333/28 , C07D333/38 , C07D307/38 , C07D409/04 , A61K31/38 , A61K31/44 , A61K31/34
CPC分类号： C07D409/04 , A61K31/341 , A61K31/365 , C07D307/38 , C07D307/58 , C07D333/16 , C07D333/18 , C07D333/28 , C07D333/38
摘要： A class of 3,4-diaryl substitued thiophene, furan and pyrrole derivatives and analogs thereof, pharmaceutical compositions containing them and methods of using them to treat inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (I), wherein Y is selected from O, S and NR1; wherein R1 is selected from hydrido and lower alkyl; wherein X is one or two substituent selected from hydrido, halo, lower alkoxycarbonyl and carboxyl; wherein R?2 and R3¿ are independently aryl or heteroaryl; and wherein R?2 and R3¿ are optionally substituted at a substitutable position with one or more radicals selected from sulfamyl, alkylsulfonyl, halo, lower alkoxy and lower alkyl; or a pharmaceutically-acceptable salt thereof.

8. 发明公开

EP0894084A1 CINNAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRIN ANTAGONISTS 失效
标题翻译：肉桂酸衍生物和它们作为整拮抗剂的用途
公开(公告)号：EP0894084A1
公开(公告)日：1999-02-03
申请号：EP97916111.0
申请日：1997-03-25
申请人： G.D. SEARLE & CO.
发明人： CHEN, Barbara, B. , CHEN, Helen, Y. , CLARE, Michael , DOCTER, Stephen, H. , KHANNA, Ish, Kumar , KOSZYK, Francis, Jan , MALECHA, James, W. , MIYASHIRO, Julie, M. , PENNING, Thomas, D. , RICO, Joseph, G. , RUMINSKI, Peter, G. , RUSSELL, Mark, A. , WEIER, Richard, M. , XU, Xiangdong , YU, Stella, S. , YU, Yi
IPC分类号： A61K31 , A61P3 , A61P9 , A61P19 , A61P35 , C07C205 , C07C275 , C07C279 , C07D231 , C07D233 , C07D239 , C07D263 , C07D279 , C07D401 , C07D403
CPC分类号： C07D231/06 , C07C205/34 , C07C205/35 , C07C205/37 , C07C205/44 , C07C205/45 , C07C205/56 , C07C205/57 , C07C275/42 , C07C279/18 , C07C279/22 , C07C279/24 , C07D233/50 , C07D233/64 , C07D239/14 , C07D239/42 , C07D263/32 , C07D279/06 , C07D401/12 , C07D403/12
摘要： The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (I), and methods of selectively inhibiting or antagonizing the αvβ3 integrin.

9. 发明公开

EP0892791A1 SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AS PRODRUGS OF COX-2 INHIBITORS 失效
标题翻译：替代苯甲酰胺衍生物ALS PRODROGEN VON COX-2 INHIBITOREN
公开(公告)号：EP0892791A1
公开(公告)日：1999-01-27
申请号：EP97921092.0
申请日：1997-04-11
申请人： G.D. SEARLE & CO.
发明人： TALLEY, John, J. , MALECHA, James, W. , BERTENSHAW, Stephen , GRANETO, Matthew, J. , CARTER, Jeffery, S. , LI, Jinglin , NAGARAJAN, Srinivasan , BROWN, David, L. , ROGIER, Donald, J., Jr. , PENNING, Thomas, D. , KHANNA, Ish, K. , XU, Xiangdong , WEIER, Richard, M.
IPC分类号： C07D , C07D233 , A61K31 , A61P1 , A61P3 , A61P5 , A61P7 , A61P9 , A61P11 , A61P13 , A61P15 , A61P17 , A61P19 , A61P21 , A61P25 , A61P27 , A61P29 , A61P31 , A61P35 , A61P37 , A61P43 , C07C311 , C07D207 , C07D231 , C07D261 , C07D263 , C07D307 , C07D401 , C07D417 , C07D495
CPC分类号： C07D207/33 , A61K31/18 , A61K31/415 , A61K31/42 , A61K31/635 , C07C311/16 , C07C311/51 , C07C2601/10 , C07D231/12 , C07D233/64 , C07D261/08 , C07D263/32 , C07D307/58 , C07D401/04 , C07D417/04 , C07D495/04
摘要： Prodrugs of COX-2 inhibitors of formula (I) are described as being useful in treating inflammation and inflammation-related disorders wherein A is a ring substituent selected from partially unsaturated heterocyclyl, heteroaryl, cycloalkenyl and aryl, wherein A is optionally substituted at a substitutable position with one or more radicals selected from alkylcarbonyl, formyl, halo, alkyl, haloalkyl, oxo, cyano, nitro, carboxyl, alkoxy, aminocarbonyl, alkoxycarbonyl, carboxyalkyl, cyanoalkyl, hydroxyalkyl, haloalkylsulfonyloxy, alkoxyalkyloxyalkyl, carboxyalkoxyalkyl, cycloalkylalkyl, alkenyl, alkynyl, heterocyclyloxy, alkylthio, cycloalkyl, aryl, heterocyclyl, cycloalkenyl, aralkyl, heterocyclylalkyl, alkylthioalkyl, arylcarbonyl, aralkylcarbonyl, aralkenyl, alkoxyalkyl, arylthioalkyl, aryloxyalkyl, aralkylthioalkyl, aralkoxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonyl, N-arylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, alkylaminocarbonylalkyl, alkylamino, N-arylamino, N-aralkylamino, N-alkyl-N-aralkylamino, N-alkyl-N-arylamino, aminoalkyl, alkylaminoalkyl, N-arylaminoalkyl, N-aralkylaminoalkyl, N-alkyl-N-aralkylaminoalkyl, N-alkyl-N-arylaminoalkyl, aryloxy, aralkoxy, arylthio, aralkylthio, alkylsulfinyl, alkylsulfonyl, aminosulfonyl, alkylaminosulfonyl, N-arylaminosulfonyl, arylsulfonyl, and N-alkyl-N-arylaminosulfonyl; wherein R1 is selected from heterocyclyl, cycloalkyl, cycloalkenyl and aryl, wherein R1 is optionally substituted at a substitutable position with one or more radicals selected from alkyl, haloalkyl, cyano, carboxyl, alkoxycarbonyl, hydroxyl, hydroxyalkyl, haloalkoxy, amino, alkylamino, arylamino, nitro, alkoxyalkyl, alkylsulfinyl, halo, alkoxy and alkylthio; wherein R2 is selected from hydrido and alkoxycarbonylalkyl; and wherein R3 is selected from alkyl, carboxyalkyl, acyl, alkoxycarbonyl, heteroarylcarbonyl, alkoxycarbonylalkylcarbonyl, alkoxycarbonylcarbonyl, amino acid residue, and alkylcarbonylaminoalkylcarbonyl; provided A is not tetrazolium, or pyridinum; and further provided A is not indanone when R3 is alkyl or carboxyalkyl; or a pharmaceutically-acceptable salt thereof.
摘要翻译：描述了式（I）的COX-2抑制剂的前药可用于治疗炎症和炎症相关疾病，其中A是选自部分不饱和杂环基，杂芳基，环烯基和芳基的环取代基，其中A任选在可取代的位置与一个或多个选自烷基羰基，甲酰基，卤素，烷基，卤代烷基，氧代，氰基，硝基，羧基，烷氧基，氨基羰基，烷氧基羰基，羧基烷基，氰基烷基，羟基烷基，卤代烷基磺酰氧基，烷氧基烷氧基烷基，羧烷氧基烷基，环烷基烷基，烯基，炔基，芳烷基，芳烷基羰基，芳烷基，烷氧基烷基，芳硫基烷基，芳氧基烷基，芳烷硫基烷基，芳烷氧基烷基，烷氧基羰基烷基，氨基羰基烷基，烷基氨基羰基，N-芳基氨基羰基，N-烷基-N- 芳基氨基羰基，烷基氨基羰基烷基，烷基氨基，N-芳基不是N-芳烷基氨基，N-烷基-N-芳烷基氨基，N-烷基-N-芳基氨基，氨基烷基，烷基氨基烷基，N-芳基氨基烷基，N-芳烷基氨基烷基，N-烷基-N-芳烷基氨基烷基，N-烷基-N-芳基氨基烷基，芳氧基，芳烷氧基，芳硫基，芳烷硫基，烷基亚磺酰基，烷基磺酰基，氨基磺酰基，烷基氨基磺酰基，N-芳基氨基磺酰基，芳基磺酰基和N-烷基-N-芳基氨基磺酰基; 其中R 1选自杂环基，环烷基，环烯基和芳基，其中R 1在可取代位置任选被一个或多个选自烷基，卤代烷基，氰基，羧基，烷氧基羰基，羟基，羟基烷基，卤代烷氧基，氨基，烷基氨基，芳基氨基，硝基，烷氧基烷基，烷基亚磺酰基，卤素，烷氧基和烷硫基; 其中R 2选自氢化和烷氧基羰基烷基; 其中R 3选自烷基，羧基烷基，酰基，烷氧基羰基，杂芳基羰基，烷氧基羰基烷基羰基，烷氧基羰基羰基，氨基酸残基和烷基羰基氨基烷基羰基。提供A不是四唑或吡啶; 并且当R 3是烷基或羧基烷基时，A不是茚满酮; 或其药学上可接受的盐。

10. 发明公开

EP0679157A1 NOVEL 3,4-DIARYL THIOPHENES AND ANALOGS THEREOF HAVING USE AS ANTIINFLAMMATORY AGENTS 有权转让
标题翻译： 3,4-diarylthiophenes及其类似物，及其作为抗炎剂。
公开(公告)号：EP0679157A1
公开(公告)日：1995-11-02
申请号：EP94906625.0
申请日：1994-01-14
申请人： G.D. SEARLE & CO. , THE MONSANTO COMPANY
发明人： BERTENSHAW, Stephen, R. , COLLINS, Paul, W. , PENNING, Thomas, D. , REITZ, David, B. , ROGERS, Roland, S.
IPC分类号： C07D333 , A61K31 , A61P19 , A61P29 , A61P43 , C07C311 , C07C317 , C07D207 , C07D213 , C07D307 , C07D401 , C07D403 , C07D405 , C07D409 , C07D413 , C07D417 , C07D471 , C07D487
CPC分类号： C07D409/04 , A61K31/341 , A61K31/365 , C07D307/38 , C07D307/58 , C07D333/16 , C07D333/18 , C07D333/28 , C07D333/38
摘要： A class of 3,4-diaryl substitued thiophene, furan and pyrrole derivatives and analogs thereof, pharmaceutical compositions containing them and methods of using them to treat inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (I), wherein Y is selected from O, S and NR1; wherein R1 is selected from hydrido and lower alkyl; wherein X is one or two substituent selected from hydrido, halo, lower alkoxycarbonyl and carboxyl; wherein R?2 and R3¿ are independently aryl or heteroaryl; and wherein R?2 and R3¿ are optionally substituted at a substitutable position with one or more radicals selected from sulfamyl, alkylsulfonyl, halo, lower alkoxy and lower alkyl; or a pharmaceutically-acceptable salt thereof.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式